DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / T••••• P•••• M•••••••
T••••• P•••• M•••••••
SeedUS
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 4
Financing history
1 rounds
- Jul 28, 2026Angel Round · amount undisclosedL•••• L••• C•••••• (lead)S•••• C•••••• (participant)T••••• C•••••• (participant)B••• O•••• C•••••• (participant)Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “T••••• P•••• M••••••• Secures Angel Round to Advance Next-Generation Ultra-Long-Acting Peptide Therapeutics”
Investors on record
4 edges
- B••• O•••• C•••••• round, participant Fact prnewswire.com
- L•••• L••• C•••••• round, lead Fact prnewswire.com
- S•••• C•••••• round, participant Fact prnewswire.com
- T••••• C•••••• round, participant Fact prnewswire.com
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
- Jul 28, 2026T••••• P•••• M••••••• announced Angel Round, led by L•••• L••• C••••••Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company
- Round announced: Angel Round Jul 28, 2026 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)